Generative AI - artificial intelligence capable of generating text, images, video, synthetic data and more - exploded onto the scene the day ChatGPT was released to the public in November, 2022. The technology’s sheer growth, in both usage and valuation, has also generated a tremendous amount of hype.
In healthcare, the technology is already beginning to demonstrate how it can reimagine the industry in new and exciting ways. Beyond easing administrative burdens and scaling tailored patient communication, generative AI is also accelerating drug discovery and clinical trials.
Generative AI is truly at the forefront of healthcare transformation, with its impact reverberating across healthcare systems, providers, payers and more.
Join VSP Global Innovation Center’s Head of Emerging Technology Jay Anderson, Insight Partners Managing Director Hilary Gosher and CB Insights Lead Analyst in Healthcare IT Alex Lennox-Miller for a discussion on the future of generative AI in healthcare, moderated by MATTER CEO Steven Collens.
For more information, visit matter.health and follow us on social:
LinkedIn @MATTER
Twitter @MATTERhealth
Instagram @matterhealth